Search
Search Results
##search.searchResults.foundPlural##
-
Osteolytic bone lesions – A rare presentation of AML M6.
2005PDF: 1116HTML: 7949Untitled: 206 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3820PDF: 1684HTML: 11635Figures Haase: 207 -
-
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7663PDF: 2448HTML: 1742Table 1.: 216Table 2.: 227Table 3.: 211Table 4.: 210 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1407HTML: 477PDF: 836 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4117PDF: 1265HTML: 1963Table 1: 204 -
MIR-140 TARGETS LNCRNA DNAJC3-AS1 TO SUPPRESS CELL PROLIFERATION IN ACUTE MYELOID LEUKEMIA AML proliferation and MIR-140 LNCRNA DNAJC3-AS1 target.
1239PDF: 607HTML: 225 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3597PDF: 2520HTML: 1499 -
-
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2353PDF: 1004HTML: 7629Untitled: 287Fig2: 189Fig3: 177Fig4: 187 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1204PDF: 768HTML: 1377Figure 1: 195Figure 2: 197 -
-
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4150PDF: 1955HTML: 5330Table 1: 201 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2047PDF: 774HTML: 3118 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2642PDF: 1632HTML: 2374Table1: 195 -
CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY
2906PDF: 1115HTML: 3036 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1308PDF: 505HTML: 207 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3381PDF: 1981HTML: 7481 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1517PDF: 1088HTML: 223 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1826PDF: 992HTML: 147 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2307PDF: 1648HTML: 276 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4348PDF: 3569HTML: 221 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1813PDF: 715HTML: 404 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2839PDF: 1023HTML: 5526 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3669PDF: 905HTML: 6722 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2458PDF: 875HTML: 2464 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1672PDF: 1250HTML: 266 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4422PDF: 1727HTML: 1048 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
505PDF: 255HTML: 79







